All In MedTech

FDA Clearance Tracker · P140003-S096

Impella 2.5, Impella CP & CP with SmartAssist, Impella 5.0/LD, Impella 5.5 with SmartAssist

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 8, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 8, 2022

Approved

Time to decision

108 days

Received Mar 22, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140003-S096
Device name
Impella 2.5, Impella CP & CP with SmartAssist, Impella 5.0/LD, Impella 5.5 with SmartAssist
Applicant
Abiomed, Inc.
Applicant location
Danvers, MA
Received
Mar 22, 2022
Decided
Jul 8, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P140003

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code OZD

FDA's approval statement

As written in FDA's record.

Approval to update the Instructions for Use to incorporate results from the Impella PCCS PAS.

Source documents

Other decisions for Abiomed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.